LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))
CAS No. ——
LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))( —— )
Catalog No. M19315 CAS No. ——
LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 298 | Get Quote |
|
| 10MG | 470 | Get Quote |
|
| 25MG | 658 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))
-
NoteResearch use only, not for human use.
-
Brief DescriptionLMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
-
DescriptionLMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetIGF-1R
-
RecptorLMPTP-A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight481.07
-
Molecular FormulaC28H37ClN4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.CCN(CC)C(=O)c1ccc(cc1)c3nc2ccccc2c(c3)NCCCN4CCCCC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stanford SM1, et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol. 2017 Jun;13(6):624-632.
molnova catalog
related products
-
AZ7550 trimesylate s...
AZ7550 trimesylate salt (AZ7550 Mesylate) is the active metabolite of ositinib, AZ7550 trimesylate salt inhibits IGF1R activity and can be used in the study of non-small cell lung cancer.
-
CTLA-4 inhibitor
CTLA-4 inhibitor is a potent CTLA-4 inhibitor.
-
NT157
NT157 is a small molecule tyrphostin targeting IRS protein and has the potential to inhibit IGF-1R and STAT3 signaling pathways in TME cancer cells and stromal cells, resulting in decreased cancer cell survival.
Cart
sales@molnova.com